299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05704036 (ClinicalTrials.gov)	March 2023	10/1/2023	Estrogen Patches for Adolescent and Young Adult Women With Cystic Fibrosis	Transdermal Estradiol for Adolescent and Young Adult Women With CF	Cystic Fibrosis;Hypoestrogenism	Drug: Transdermal estrogen;Drug: Placebo patch;Drug: Progesterone;Drug: Placebo pill	Johns Hopkins University	Cystic Fibrosis Foundation	Recruiting	16 Years	30 Years	Female	75	Phase 4	United States
2	NCT03724955 (ClinicalTrials.gov)	April 2019	29/10/2018	Pilot E2 for Hypogonadal Women With CFBD	Pilot Study Evaluating the Effects of Estradiol for Hypogonadal Women With Cystic Fibrosis and Osteopenia	Cystic Fibrosis Related Bone Disease	Drug: Estradiol 2 mg;Other: Placebo	Emory University	NULL	Withdrawn	18 Years	N/A	Female	0	Phase 4	United States
3	NCT02144246 (ClinicalTrials.gov)	May 2014	19/5/2014	Contraceptive Hormones and Women With Cystic Fibrosis	Contraceptive Hormones and Women With Cystic Fibrosis: Satisfaction and Effects on Disease	Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception	Other: Non-hormonal period;Drug: Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg	University of Pennsylvania	Society of Family Planning	Terminated	18 Years	40 Years	Female	5	Phase 1	United States
4	NCT02036879 (ClinicalTrials.gov)	February 2014	26/12/2013	Gender Disparity and Hormones in Cystic Fibrosis	Gender Disparity and Hormones in Cystic Fibrosis	Cystic Fibrosis (CF)	Drug: Loestrin (norethindrone acetate and ethinyl estradiol)	University of Texas Southwestern Medical Center	NULL	Completed	18 Years	N/A	All	55	Early Phase 1	United States